Corona: Soon the children will also be vaccinated, the government orders the vaccine of 1 crore to Zydus Cadila – The Center places a purchase order for a dose of one crore of Zydus Cadila of three doses of the vaccine Covid ZyCoV D ntc

History highlights

  • 1 crore of vaccine doses ordered
  • The company can provide 10 million doses of ZyCoV-D each month.
  • This is the first vaccine approved for people 12 years of age and older.

Zydus Cadila’s three-dose covid vaccine, ZyCoV-D, will be included in the national coronavirus vaccination program this month. Because now children in India will also be able to get the corona vaccine soon. The government has ordered a crore of doses of this vaccine from the Ahmedabad-based company Zydus Cadila.

According to the agency, the Health Ministry approved to begin preparatory work for the introduction of the world’s first indigenous DNA-based Kovid vaccine. It is believed that as part of the country’s vaccination campaign, this vaccine will initially be administered to adults.

ZyCoV-D is the first vaccine approved by India’s drug regulator for people 12 years of age and older.

An official source says: “The Center has placed an order for Zydus Cadila for one crore dose of ZyCoV-D. The cost for a single dose is around Rs 358, which does not include tax. This price includes the cost of one Disposable jet applicator. This vaccine is also used with which this vaccine is administered. Due to limited production capacity, this vaccine will initially be administered to adults. “

Zydus Cadila officials have told the government that the company can provide one crore dose of ZyCoV-D each month.

Front-line workers and vaccinators will also be trained to use the jet applicator to administer this vaccine, as this vaccine is not injected with a needle. Three doses of ZyCoV-D will be administered 28 days apart. Each dose will be administered in both arms.

The Committee of Experts on the Matter (SEC) of the Central Medicines Authority recommended on October 12 to grant emergency use authorization to Covaxin for children and adolescents from 2 to 18 years old, subject to certain conditions.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *